| Recruitment status | No longer recruiting |
| Unique ID issued by UMIN | UMIN000032258 |
| Receipt No. | R000036789 |
| Official scientific title of the study | The Clinical Study evaluating correlation between BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro BNP) |
| Date of disclosure of the study information | 2018/04/16 |
| Last modified on | 2018/04/16 (Ver. 1) |
| Basic information | ||
| Official scientific title of the study | The Clinical Study evaluating correlation between BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro BNP) | |
| Title of the study (Brief title) | The Clinical Study evaluating correlation between BNP and NT-proBNP | |
| Region |
|
|
| Condition | ||
| Condition | Cardiovascular disease | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To elucidate correlation between BNP (B-type natriuretic peptide) and NT-proBNP (N-terminal pro BNP). |
| Basic objectives2 | Others |
| Basic objectives -Others | Development of conversion equation. |
| Trial characteristics_1 | Others |
| Trial characteristics_2 | Others |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | BNP and NT-proBNP. |
| Key secondary outcomes | Clinical information (sex, age, height, body weight, blood pressure, heart rate, SAS, NYHA class, HF stage class, heart disease, echocardiogram, blood test, urine test, chest X-ray, electrocardiogram, drug allergy, past history, smoking, drinking, family history). |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | All patients whose BNP and NT-proBNP were measured at Department of Cardiovascular Medicine, Tohoku University Hospital. | |||
| Key exclusion criteria | Patients who were judged to be not eligible in the present study by the physician in charge. | |||
| Target sample size | 3000 | |||
| Research contact person | |
| Name of lead principal investigator | Yasuhiko Sakata |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-1, Seiryomachi, Aoba-ku, Sendai, Japan |
| TEL | 022(717)7153 |
| sakatayk@cardio.med.tohoku.ac.jp | |
| Public contact | |
| Name of contact person | Yasuhiko Sakata |
| Organization | Tohoku University Graduate School of Medicine |
| Division name | Department of Cardiovascular Medicine |
| Address | 1-1, Seiryomachi, Aoba-ku, Sendai, Japan |
| TEL | 022(717)7153 |
| Homepage URL | |
| sakatayk@cardio.med.tohoku.ac.jp | |
| Sponsor | |
| Institute | Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | None |
| Name of secondary funder(s) | None |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 東北大学(宮城県) |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | No longer recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | Retrospective study. All adult patients whose BNP and NT-proBNP were measured at Department of Cardiovascular Medicine, Tohoku University Hospital between April 2017 and October 2017. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036789 |